Mealey?s Emerging Drugs & Devices [Published: 2018-07-12 to 2018-09-20. Issues: vol. 23, no. 13, July 12, 2018 to vol. 23, no. 18, September 20, 2018]

Serial Registration

Mealey?s Emerging Drugs & Devices [Published: 2018-07-12 to 2018-09-20. Issues: vol. 23, no. 13, July 12, 2018 to vol. 23, no. 18, September 20, 2018]

Status

Published

on 2 Oct 2018

Year of Creation

2018

LexisNexis Mealey's

Registration Number

TX0008685092

on 2 Oct 2018

The U.S. Copyright record (Registration Number: TX0008685092) dated 2 Oct 2018, pertains to an electronic file (eService) titled "Mealey?s Emerging Drugs & Devices [Published: 2018-07-12 to 2018-09-20. Issues: vol. 23, no. 13, July 12, 2018 to vol. 23, no. 18, September 20, 2018]" created in 2018. The copyright holder is LexisNexis Mealey's, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to LexisNexis Mealey's.

LexisNexis Mealey's

Application Details

Registration Number

TX0008685092

Registration Date

10/2/2018

Year of Creation

2018

Agency Marc Code

DLC-CO

Record Status

Changed

Corporate Author

LexisNexis Mealey's

First Publication Nation

United States

ISSN

1524-9573

Corporate Authors

LexisNexis Mealey's

Notes

Copyright Local Holdings: vol. 23, no. 13, July 12, 2018 (C.O. correspondence) Pub. 2018-07-12 Reg. 2019-02-25 TX0008685092 PSTANvol. 23, no. 14, July 26, 2018 (C.O. correspondence) Pub. 2018-07-26 Reg. 2019-02-25 TX0008685092 PSTANvol. 23, no. 15, August 2, 2018 (C.O. correspondence) Pub. 2018-08-02 Reg. 2019-02-25 TX0008685092 PSTANvol. 23, no. 16, August 16, 2018 (C.O. correspondence) Pub. 2018-08-16 Reg. 2019-02-25 TX0008685092 PSTANvol. 23, no. 17, September 6, 2018 (C.O. correspondence) Pub. 2018-09-06 Reg. 2019-02-25 TX0008685092 PSTANvol. 23, no. 18, September 20, 2018 (C.O. correspondence) Pub. 2018-09-20 Reg. 2019-02-25 TX0008685092 PSTAN

Local Copyright Note: C.O. correspondence

Statements

Application Title Statement: Mealey?s Emerging Drugs & Devices

Author Statement: LexisNexis Mealey's employer for hire Authorship: collective work

Notes

Local Copyright Note: C.O. correspondence

Statements

Application Title Statement: Mealey?s Emerging Drugs & Devices

Author Statement: LexisNexis Mealey's employer for hire Authorship: collective work

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.